Screening status, tumour subtype, and breast cancer survival: a national population-based analysis

被引:30
作者
O'Brien, Katie M. [1 ,2 ]
Mooney, Therese [3 ]
Fitzpatrick, Patricia [3 ,4 ]
Sharp, Linda [5 ]
机构
[1] Natl Canc Registry Ireland, Cork T12 CDF7, Ireland
[2] Cork Inst Technol, Dept Math, Cork T12 P928, Ireland
[3] Natl Screening Serv, Kings Inns House,200 Parnell St, Dublin 1, Ireland
[4] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin 4, Ireland
[5] Newcastle Univ, Inst Hlth & Soc, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England
关键词
Breast cancer; Screening; Subtypes; Survival; Non-proportional hazards; MAMMOGRAPHY; WOMEN; BENEFITS; HARMS;
D O I
10.1007/s10549-018-4877-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeWe examined whether demographic and tumour characteristics (including subtype) were different for women with breast cancer diagnosed via mammography screening compared with women with interval breast cancers, lapsed attenders of the screening programme and non-participants of the screening programme. In addition, we explored whether there were survival differences between the groups, taking into account lead time bias.MethodsWe used linked data from National Cancer Registry Ireland and the national breast screening programme BreastCheck. Multinomial logistic regression was used to test the association of covariates with screening status. For survival analysis, we corrected the survival time for screen-detected cases for lead time bias, examined Kaplan-Meier curves and then used Cox regression to investigate differences in survival by screening status.ResultsSubtype (HER2 over-expressing, triple negative), stage (III/IV), grade (poor), having co-morbidities, area of deprivation, smoking status and age were associated with having interval cancer or being a non-participant of the screening programme in the multivariable model. After correcting for lead time bias, and adjusting for variables associated with screening status, there was no evidence that risk of breast-cancer death for women with screen-detected cancer was different from women with interval cancer (HR=0.76, 95% CI 0.56-1.03), non-participants (HR=1.07, 95% CI 0.84-1.37) and lapsed attenders (HR=0.97, 95% CI 0.65-1.45).ConclusionsScreening status was strongly associated with subtype and this association persisted after adjustment for covariates including tumour stage and grade. After correcting for lead-time bias and adjusting for stage, subtype, grade and socio-demographic variables, no significant survival difference was demonstrated for women with screen-detected cancer in the 5-year period post-diagnosis. Since we are adjusting for stage, subtype and other variables, the lack of difference between these groups would be expected but has not been demonstrated in studies which do not correct for lead time bias.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 30 条
[1]   Explaining the difference in prognosis between screen-detected and symptomatic breast cancers [J].
Allgood, P. C. ;
Duffy, S. W. ;
Kearins, O. ;
O'Sullivan, E. ;
Tappenden, N. ;
Wallis, M. G. ;
Lawrence, G. .
BRITISH JOURNAL OF CANCER, 2011, 104 (11) :1680-1685
[2]   Psychosocial predictors of first attendance for organised mammography screening [J].
Aro, AR ;
de Koning, HJ ;
Absetz, P ;
Schreck, M .
JOURNAL OF MEDICAL SCREENING, 1999, 6 (02) :82-88
[3]   Two distinct groups of non-attenders in an organized mammography screening program [J].
Aro, AR ;
de Koning, HJ ;
Absetz, P ;
Schreck, M .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 70 (02) :145-153
[4]   Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program [J].
Bare, Marisa ;
Tora, Nuria ;
Salas, Dolores ;
Sentis, Melchor ;
Ferrer, Joana ;
Ibanez, Josefa ;
Zubizarreta, Raquel ;
Sarriugarte, Garbine ;
Barata, Teresa ;
Domingo, Laia ;
Castells, Xavier ;
Sala, Maria .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 154 (02) :403-415
[5]   Interval Breast Cancer Versus Screen-Detected Cancer: Comparison of Clinicopathologic Characteristics in a Single-Center Analysis [J].
Bellio, Gabriele ;
Marion, Riccardo ;
Giudici, Fabiola ;
Kus, Sara ;
Tonutti, Maura ;
Zanconati, Fabrizio ;
Bortul, Marina .
CLINICAL BREAST CANCER, 2017, 17 (07) :564-571
[6]  
Black R, 2000, TRENDS CANC SURVIVAL
[7]   Impact of screening mammography on breast cancer mortality [J].
Bleyer, Archie ;
Baines, Cornelia ;
Miller, Anthony B. .
INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (08) :2003-2012
[8]   Mammographic features associated with interval breast cancers in screening programs [J].
Boyd N.F. ;
Huszti E. ;
Melnichouk O. ;
Martin L.J. ;
Hislop G. ;
Chiarelli A. ;
Yaffe M.J. ;
Minkin S. .
Breast Cancer Research, 16 (4)
[9]   Which women with breast cancer do, and do not, undergo receptor status testing? A population-based study [J].
Cancela, Marianna de Camargo ;
Comber, Harry ;
Sharp, Linda .
CANCER EPIDEMIOLOGY, 2015, 39 (05) :778-782
[10]   Do women who intermittently attend breast screening differ from those who attend every invitation and those who never attend? [J].
Coyle, C. ;
Kinnear, H. ;
Rosato, M. ;
Mairs, A. ;
Hall, C. ;
O'Reilly, D. .
JOURNAL OF MEDICAL SCREENING, 2014, 21 (02) :98-103